FDA inspection
Replidyne, Inc.: FDA inspection ending Oct 17, 2006
FDA inspection 446301 · Official Action Indicated (OAI) · Louisville, CO
Key facts
| Inspection ID | 446301 |
|---|---|
| Firm | Replidyne, Inc. |
| FEI number | 3005681620 |
| Address | 1450 Infinite Dr |
| City | Louisville |
| State | CO |
| ZIP | 80027-9440 |
| Fiscal year | 2007 |
| Inspection end date | Oct 17, 2006 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data